PPMI at MDS 2017

The 21st International Congress of Parkinson’s Disease and Movement Disorders (MDS) conference will take place next week, June 4-8, in Vancouver, Canada. PPMI leadership is happy to announce that several posters will feature PPMI data. We invite you to look for PPMI at this year’s meeting:

Blue Ribbon Highlight: 

840 Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson’s disease. Presenter: Daniel Weintraub

Dr. Weintraub’s poster will be on display on Wednesday, June 7. You can hear more about the publication during the Blue Ribbon Highlights session on Thursday, June 8, from 11:00 12:00.

Posters with Steering Committee driven analyses:

Thursday, June 8

1395 Sample size estimation for clinical trials in de novo Parkinson’s disease (PD): Results from the Parkinson’s Progression Markers Initiative (PPMI) study. Presenter: Tanya Simuni

1400 Five year longitudinal change in MDS-UPDRS scores in early Parkinson’s disease participants: Results from the PPMI study. Presenter: Tanya Simuni

1566 Patterns of Striatal DAT Binding Loss in Progressing Parkinson’s disease (PD) Cohort: Four year PPMI Follow-up. Presenter: John Seibyl

Posters utilizing PPMI data:

Monday, June 5

129 Non-motor freature of p.A53T alpha-synuclein mutation carriers compared to sporadic Parkinson’s disease in a PPMI cohort. Presenter: Maria Stamelou

223 Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort. Presenter: Darko Aleksovski

Wednesday, June 7

941 Cognitive data in the Parkinson’s Progression Markers Initiative: Comparison of normative data approaches. Kathryn Wyman-Chick

1042 Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease. Presenter: Dheeraj Bobbili

Thursday, June 8

1404 Innovative recruitment strategies accelerate enrollment of genetic mutation carriers in the Parkinson’s Progression Markers Initiative (PPMI). Presenter: Vanessa Arnedo

1425 Physical Activity Habits in Early Parkinson’s Disease and Healthy Controls. Presenter: Amy Amara

1466 Clinical Utility of Optimized Parameters for a Quantitative Analysis of 123-ioflupane SPECT (DaTscan) images. Presenter: George Zubal